Android Apple

Trial of Controversial Alzheimer's Drug Halted After Disappointing Results

By The New York Times   |   3 weeks ago
Trial of Controversial Alzheimer's Drug Halted After Disappointing Results

Cassava Sciences halted an Alzheimer's drug trial after finding it did not reduce cognitive decline in 1,900 patients. The company faced controversy over its research methods and misleading statements, causing a significant drop in stock price and uncertainty about its future.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.